NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

TBO Tek Posts Resilient 4QFY26 Performance Amid Geopolitical Disruptions

TBO Tek has reported a robust 4QFY26 performance, defying the challenging global economic landscape. The company's revenue skyrocketed 83% year-over-year (YoY) to INR8.14 billion (est. INR7.06 billion), driven in part by the consolidation of Classic Vacations. Organic revenue growth was equally impressive, increasing 21% YoY to INR5.42 billion.

Metric4QFY264QFY25
4Q MTB (Reported)32,751 (+15% YoY)-
4Q MTB (Organic)30,063 (+6% YoY)-
4Q EBITDAINR1.05 billion (est. INR988 million)-
FY26 EBITDAINR3.78 billion (est. INR3.72 billion)-

The company's 4Q EBITDA stood at INR1.05 billion, marginally below estimates at 12.9% (est. 14.0%). However, FY26 EBITDA came in at INR3.78 billion, exceeding estimates at 14.1% (est. 14.5%). On a YoY basis, PAT increased by 2% to INR601 million (est. INR568 million) in 4Q, while FY26 PAT stood at INR2.44 billion (est. INR2.41 billion).

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

TBO Tek's Outlook Remains Strong

We believe TBO Tek has delivered a solid set of numbers despite the challenging operating environment. The company is expected to deliver a compound annual growth rate (CAGR) of 37%/35%/30% in revenue/EBIT/PAT over FY25-28, primarily driven by increased contributions from high take-rate hotels and ancillary segments in the gross transaction value (GTV) mix. We reiterate our BUY rating on TBO Tek with a target price of INR1,485, valued at 32x FY28E EPS.

Investor Takeaway

Investors should consider TBO Tek for its strong performance and growth prospects.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.